Table 3. Patients with early-stage pancreatic cancer.
Age | Sex | Tumor diameter (mm) | Tumor location | Pathology | ly | v | p Stage | CEA (ng/ml) | CA19-9 (U/ml) | Preoperative | Postoperative | Postoperative index − Preoperative index Δ index (×10) | Preoperative | Postoperative | Postoperative index − Preoperative index Δ index (×100) | Days after operation for postoperative sampling |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N-NOSE index (×10) | N-NOSE index (×10) | N-NOSE index (×100) | N-NOSE index (×100) | |||||||||||||
74 | F | 4 | Ph | Carcinoma in situ | 0 | 0 | 0 | 4.8 | 16.3 | 0.044 | −0.036 | −0.080* | 0.016 | −0.015 | −0.031* | 33 |
67 | F | 8 | Pb | Carcinoma in situ | 0 | 0 | 0 | 0.8 | 2.5 | −0.028 | −0.051 | −0.023* | 0.004 | 0.003 | −0.001* | 85 |
84 | F | 13 | Pb | Carcinoma in situ | 0 | 0 | 0 | 1.4 | 7.8 | 0.020 | −0.055 | −0.075* | 0.048 | 0.002 | −0.046* | 38 |
66 | M | 10 | Ph | Poorly differentiated | 0 | 0 | IA | 3.0 | 18.4 | −0.015 | −0.004 | 0.011 | 0.050 | −0.039 | −0.089* | 42 |
82 | F | 18 | Ph | Moderately differentiated | 0 | 2 | IA | 3.6 | 50.8* | −0.021 | −0.031 | −0.010* | −0.038 | −0.063 | −0.025* | 41 |
66 | F | 10 | Ph | Moderately differentiated | 0 | 0 | IA | 3.4 | 24.0 | 0.049 | 0.090 | 0.041 | 0.047 | −0.021 | −0.068* | 27 |
76 | M | 16 | Ph | Moderately differentiated | 0 | 0 | IA | 4.7 | 58.0* | 0.048 | −0.095 | −0.143* | −0.078 | −0.073 | 0.005 | 84 |
69 | F | 18 | Ph | Moderately differentiated | 1 | 1 | IA | 1.7 | 18.9 | −0.038 | −0.035 | 0.003 | 0.001 | 0.059 | 0.058 | 41 |
71 | M | 10 | Ph | Well differentiated | 0 | 0 | IA | 3.8 | 15.0 | −0.045 | 0.020 | 0.065 | 0.123 | 0.124 | 0.001 | 35 |
58 | M | 10 | Pb | Well differentiated | 0 | 0 | IA | 3.9 | 2.0 | −0.028 | 0.009 | 0.037 | −0.055 | 0.008 | 0.063 | 34 |
64 | F | 2 | Ph | Well differentiated | 0 | 0 | IA | 2.0 | 41.0* | 0.003 | 0.093 | 0.090 | 0.149 | 0.237 | 0.088 | 84 |
Abbreviations: Ph: pancreatic head; Pb: pancreatic body; ly: lymph node invasion; venous invasion; pStage, pathological stage. According to the pancreatic cancer database of the Japanese Pancreas Society (http://www.suizou.org/english/index.htm), classification is shown: ly, lymph node invasion; venous invasion; pStage, pathological stage. *Patients determined to be positive.